Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 584.04 Million CNY | -9.87% |
| 2022 | 648.03 Million CNY | 11.73% |
| 2021 | 580 Million CNY | 9.28% |
| 2020 | 530.73 Million CNY | -1.41% |
| 2019 | 538.35 Million CNY | 1.17% |
| 2018 | 532.11 Million CNY | 0.2% |
| 2017 | 531.05 Million CNY | 2.35% |
| 2016 | 518.85 Million CNY | 20.44% |
| 2015 | 430.78 Million CNY | -11.45% |
| 2014 | 486.5 Million CNY | 30.41% |
| 2013 | 373.05 Million CNY | 28.79% |
| 2012 | 289.65 Million CNY | 25.89% |
| 2011 | 230.08 Million CNY | 45.65% |
| 2010 | 157.97 Million CNY | 39.29% |
| 2009 | 113.41 Million CNY | 28.43% |
| 2008 | 88.3 Million CNY | 21.12% |
| 2007 | 72.9 Million CNY | 56.66% |
| 2006 | 46.53 Million CNY | -20.49% |
| 2005 | 58.53 Million CNY | -8.44% |
| 2004 | 63.93 Million CNY | -6.28% |
| 2003 | 68.21 Million CNY | 12.73% |
| 2002 | 60.51 Million CNY | -17.18% |
| 2001 | 73.06 Million CNY | -12.64% |
| 2000 | 83.63 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 157.53 Million CNY | 0.0% |
| 2024 Q1 | 157.53 Million CNY | -8.57% |
| 2023 Q3 | 145.71 Million CNY | -11.82% |
| 2023 Q1 | 100.78 Million CNY | -43.45% |
| 2023 Q2 | 165.23 Million CNY | 63.94% |
| 2023 FY | 584.04 Million CNY | -9.87% |
| 2023 Q4 | 172.3 Million CNY | 18.25% |
| 2022 FY | 648.03 Million CNY | 11.73% |
| 2022 Q3 | 171.96 Million CNY | 26.46% |
| 2022 Q4 | 178.23 Million CNY | 3.65% |
| 2022 Q1 | 161.86 Million CNY | -19.23% |
| 2022 Q2 | 135.98 Million CNY | -15.99% |
| 2021 Q1 | 125.36 Million CNY | -19.82% |
| 2021 Q3 | 140.5 Million CNY | 23.53% |
| 2021 FY | 580 Million CNY | 9.28% |
| 2021 Q4 | 200.39 Million CNY | 42.63% |
| 2021 Q2 | 113.74 Million CNY | -9.27% |
| 2020 Q1 | 111.38 Million CNY | -21.66% |
| 2020 Q2 | 131.89 Million CNY | 18.42% |
| 2020 Q3 | 131.1 Million CNY | -0.6% |
| 2020 Q4 | 156.36 Million CNY | 19.27% |
| 2020 FY | 530.73 Million CNY | -1.41% |
| 2019 FY | 538.35 Million CNY | 1.17% |
| 2019 Q4 | 142.16 Million CNY | -3.46% |
| 2019 Q3 | 147.25 Million CNY | 12.82% |
| 2019 Q1 | 118.39 Million CNY | -11.43% |
| 2019 Q2 | 130.52 Million CNY | 10.25% |
| 2018 FY | 532.11 Million CNY | 0.2% |
| 2018 Q3 | 141.92 Million CNY | 15.17% |
| 2018 Q4 | 133.67 Million CNY | -5.82% |
| 2018 Q2 | 123.23 Million CNY | -7.54% |
| 2018 Q1 | 133.28 Million CNY | -1.11% |
| 2017 Q2 | 124.7 Million CNY | -0.29% |
| 2017 Q3 | 146.5 Million CNY | 17.49% |
| 2017 FY | 531.05 Million CNY | 2.35% |
| 2017 Q4 | 134.78 Million CNY | -8.0% |
| 2017 Q1 | 125.05 Million CNY | -10.92% |
| 2016 FY | 518.85 Million CNY | 20.44% |
| 2016 Q4 | 140.38 Million CNY | 0.99% |
| 2016 Q3 | 139 Million CNY | 19.47% |
| 2016 Q2 | 116.35 Million CNY | -5.48% |
| 2016 Q1 | 123.1 Million CNY | 18.04% |
| 2015 FY | 430.78 Million CNY | -11.45% |
| 2015 Q1 | 102.1 Million CNY | -43.31% |
| 2015 Q2 | 114.99 Million CNY | 12.62% |
| 2015 Q3 | 109.38 Million CNY | -4.88% |
| 2015 Q4 | 104.29 Million CNY | -4.65% |
| 2014 Q2 | 107.99 Million CNY | 21.08% |
| 2014 FY | 486.5 Million CNY | 30.41% |
| 2014 Q4 | 180.11 Million CNY | 64.93% |
| 2014 Q3 | 109.2 Million CNY | 1.12% |
| 2014 Q1 | 89.19 Million CNY | -19.44% |
| 2013 Q3 | 88.87 Million CNY | -6.11% |
| 2013 FY | 373.05 Million CNY | 28.79% |
| 2013 Q1 | 78.8 Million CNY | -10.76% |
| 2013 Q2 | 94.65 Million CNY | 20.11% |
| 2013 Q4 | 110.72 Million CNY | 24.58% |
| 2012 Q4 | 88.3 Million CNY | 5.83% |
| 2012 Q2 | 117.9 Million CNY | 104.1% |
| 2012 FY | 289.65 Million CNY | 25.89% |
| 2012 Q1 | 57.76 Million CNY | -27.49% |
| 2012 Q3 | 83.44 Million CNY | -29.23% |
| 2011 Q1 | 39.96 Million CNY | -3.65% |
| 2011 Q2 | 50.54 Million CNY | 26.45% |
| 2011 Q3 | 59.9 Million CNY | 18.53% |
| 2011 Q4 | 79.67 Million CNY | 33.0% |
| 2011 FY | 230.08 Million CNY | 45.65% |
| 2010 Q1 | 29.89 Million CNY | 0.0% |
| 2010 FY | 157.97 Million CNY | 39.29% |
| 2010 Q3 | 33.71 Million CNY | -36.25% |
| 2010 Q4 | 41.47 Million CNY | 23.03% |
| 2010 Q2 | 52.88 Million CNY | 76.91% |
| 2009 FY | 113.41 Million CNY | 28.43% |
| 2009 Q2 | 27.9 Million CNY | 0.0% |
| 2008 FY | 88.3 Million CNY | 21.12% |
| 2007 FY | 72.9 Million CNY | 56.66% |
| 2006 FY | 46.53 Million CNY | -20.49% |
| 2005 FY | 58.53 Million CNY | -8.44% |
| 2004 FY | 63.93 Million CNY | -6.28% |
| 2003 FY | 68.21 Million CNY | 12.73% |
| 2002 FY | 60.51 Million CNY | -17.18% |
| 2001 FY | 73.06 Million CNY | -12.64% |
| 2000 FY | 83.63 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -248.817% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 91.048% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -1929.417% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -47.93% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 1740.44% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -5.938% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 62.058% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -23.924% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -169.607% |
| SSY Group Limited | 3.48 Billion HKD | 83.261% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -82.848% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | 5.871% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 98.653% |